Zota Health Care LImited — JV/Acquisition, 22-06-2026: Acquisition

Zota Health Care (ZOTA) has infused ₹2 crore into its wholly-owned subsidiary, Curexis Ventures. This strategic capital injection, by way of subscribing to a rights issue, aims to fuel the expansion of Curexis's "SKIA" retail pharmacy stores and address working capital needs. Curexis specializes in drug manufacturing, development, and marketing, also operating pharmacy outlets offering a wide range of products. This move reinforces Zota's commitment to strengthening its retail pharmacy footprint and scaling an existing key business segment.